Clinical Trial Update: ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab [Phase 1]

View source ↗

Summary

Phase 1 trial update for ASTX660 in combination with pembrolizumab in advanced cancers, including cervical cancer and triple-negative breast cancer; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• ASTX660
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Advanced Cancer, Cervical Cancer | Phase 1 | Status: RECRUITING